Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Computer-aided design and implementation of efficient biosynthetic pathways to produce high added-value products derived from tyrosine in &lt, i&gt, Escherichia coli&lt, /i&gt

  • Ferreira, Sofia
  • Balola, Alexandra
  • Sveshnikova, Anastasia
  • Hatzimanikatis, Vassily
  • Vilaça, Paulo
  • Maia, Paulo
  • Carreira, Rafael
  • Stoney, Ruth
  • Souza, Caio Silva
  • Correia, Joao
  • Lousa, Diana
  • Soares, Claudio M.
  • Rocha, Isabel
  • Carbonell, Pablo|||0000-0002-0993-5625
[EN] Developing efficient bioprocesses requires selecting the best biosynthetic pathways, which can be challenging and time-consuming due to the vast amount of data available in databases and literature. The extension of the shikimate pathway for the biosynthesis of commercially attractive molecules often involves promiscuous enzymes or lacks well-established routes. To address these challenges, we developed a computational workflow integrating enumeration/retrosynthesis algorithms, a toolbox for pathway analysis, enzyme selection tools, and a gene discovery pipeline, supported by manual curation and literature review. Our focus has been on implementing biosynthetic pathways for tyrosine-derived compounds, specifically L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine, with significant applications in health and nutrition. We selected one pathway to produce L-DOPA and two different pathways for dopamine-one already described in the literature and a novel pathway. Our goal was either to identify the most suitable gene candidates for expression in Escherichia coli for the known pathways or to discover innovative pathways. Although not all implemented pathways resulted in the accumulation of target compounds, in our shake-flask experiments we achieved a maximum L-DOPA titer of 0.71 g/L and dopamine titers of 0.29 and 0.21 g/L for known and novel pathways, respectively. In the case of L-DOPA, we utilized, for the first time, a mutant version of tyrosinase from Ralstonia solanacearum. Production of dopamine via the known biosynthesis route was accomplished by coupling the L-DOPA pathway with the expression of DOPA decarboxylase from Pseudomonas putida, resulting in a unique biosynthetic pathway never reported in literature before. In the context of the novel pathway, dopamine was produced using tyramine as the intermediate compound. To achieve this, tyrosine was initially converted into tyramine by expressing TDC from Levilactobacillus brevis, which, in turn, was converted into dopamine through the action of the enzyme encoded by ppoMP from Mucuna pruriens. This marks the first time that an alternative biosynthetic pathway for dopamine has been validated in microbes. These findings underscore the effectiveness of our computational workflow in facilitating pathway enumeration and selection, offering the potential to uncover novel biosynthetic routes, thus paving the way for other target compounds of biotechnological interest., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement 814408 SHIKIFACTORY100-Modular cell factories for the production of 100 compounds from the Shikimate pathway. This work was supported by FCT-Fundacao para a Ciencia e a Tecnologia, I.P., through MOSTMICRO-ITQB R&D Unit (UIDB/04612/2020, UIDP/04612/2020) and LS4FUTURE Associated Laboratory (LA/P/0087/2020).r The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement 814408 SHIKIFACTORY100-Modular cell factories for the production of 100 compounds from the Shikimate pathway. This work was supported by FCT-Fundac & atilde;o para a Ciencia e a Tecnologia, I.P., through MOSTMICRO-ITQB R&D Unit (UIDB/04612/2020, UIDP/04612/2020) and LS4FUTURE Associated Laboratory (LA/P/0087/2020).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SelenzymeRF: updated enzyme suggestion software for unbalanced biochemical reactions

  • Stoney, Ruth A.
  • Hanko, Erik K. R.
  • Breitling, Rainer
  • Carbonell, Pablo|||0000-0002-0993-5625
[EN] Selenzyme is a retrobiosynthesis tool that suggests candidate enzymes for user query reactions. Enzyme suggestions are based on identical reactions, as well as similar reactions, since enzymes are often capable of promiscuous substrate binding. Selenzyme is a user-friendly, widely used web-tool for ranking enzymes based on reaction similarity and additional features, including the phylogenetic distance between the source species of the enzyme and the intended host. While Selenzyme has proved invaluable in assisting with enzyme selection for known reactions, as well as many novel or orphan reactions, weaknesses have been exposed in its ability to rank functionally related enzymes. Within this update, we introduce a new reaction similarity scoring algorithm, which is used in conjunction with the previous similarity calculation, to improve the accuracy of enzyme suggestions based on non-identical similar reactions, across a range of EC reaction classes. This allows enzymes to be suggested for reactions not found within the database, even if the reaction is unbalanced. A database update was also carried out, to ensure that reaction and enzyme knowledge remains current. This update can be accessed at http://selenzymeRF.synbiochem.co.uk/., This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement 814408 SHIKIFACTORY100-Modular cell factories for the production of 100 compounds from the shikimate pathway.We acknowledge funding from the Biotechnology and Biological Sciences Research Council (BBSRC) under grant BB/M017702/1 "Centre for synthetic biology of fine and speciality chemicals (SYNBIOCHEM)". Pablo Carbonell was supported by the Spanish Ministry of Universities (UNI/551/2021), grant number UP2021-036 funded by European Union-Next generation EU.Pablo Carbonell acknowledges funding from Generalitat Valenciana through grant CIAICO/2021/159 (SmartBioFab). Pablo Carbonell acknowledges MCIN/AEI/10.13039/ 501100011033 and NextGenerationEU/ PRTR funding through grant TED2021-131049B-I00 (BioEcoDBTL).
RUC. Repositorio da Universidade da Coruña
Publicación Contribución de congreso (ConferenceOutput)

Gene variant space for biosensor-based dynamic regulation

  • Camarena, María
  • Boada, Yadira
  • Picó, Jesús
  • Carbonell, Pablo
[Abstract] Inside a cell, protein, production and biosensor pathways can be genetically engineered within a dynamic regulation architecture that provides robustness to cell factories. Here we investigated how the selection of gene variants and their associated expression efficiency and kinetic parameters can lead to a wide diversity of dynamic responses in terms of protein or metabolite production. Results show that there is a trade-off between gene expression efficiency and pathway performance, and it can be eventually related to the evolutionary fingerprint of each gene variant. Therefore, the organism source of gene variants is a factor that needs to be considered in the design of dynamic regulation for genetic circuits., Ministerio de Economía y Empresa; DPI2017-82896-C2-1-R, Ministerio de Ciencia e Innovación; PID2020-117271RB-C21
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathways to cellular supremacy in biocomputing

  • Grozinger, Lewis
  • Amos, Martyn
  • Gorochowski, Thomas E.
  • Carbonell, Pablo
  • Oyarzún, Diego A.
  • Stoof, Ruud
  • Fellermann, Harold
  • Zuliani, Paolo
  • Tas, Huseyin
  • Goñi-Moreno, Ángel
Synthetic biology uses living cells as the substrate for performing human-defined computations. Many current implementations of cellular computing are based on the “genetic circuit” metaphor, an approximation of the operation of silicon-based computers. Although this conceptual mapping has been relatively successful, we argue that it fundamentally limits the types of computation that may be engineered inside the cell, and fails to exploit the rich and diverse functionality available in natural living systems. We propose the notion of “cellular supremacy” to focus attention on domains in which biocomputing might offer superior performance over traditional computers. We consider potential pathways toward cellular supremacy, and suggest application areas in which it may be found., A.G.-M. was supported by the SynBio3D project of the UK Engineering and Physical Sciences Research Council (EP/R019002/1) and the European CSA on biological standardization BIOROBOOST (EU grant number 820699). T.E.G. was supported by a Royal Society University Research Fellowship (grant UF160357) and BrisSynBio, a BBSRC/ EPSRC Synthetic Biology Research Centre (grant BB/L01386X/1). P.Z. was supported by the EPSRC Portabolomics project (grant EP/N031962/1). P.C. was supported by SynBioChem, a BBSRC/EPSRC Centre for Synthetic Biology of Fine and Specialty Chemicals (grant BB/M017702/1) and the ShikiFactory100 project of the European Union’s Horizon 2020 research and innovation programme under grant agreement 814408.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Automated engineering of synthetic metabolic pathways for efficient biomanufacturing

  • Otero-Muras, Irene
  • Carbonell, Pablo
20 pages, 6 figures, 3 tables, Metabolic engineering involves the engineering and optimization of processes from single-cell to fermentation in order to increase production of valuable chemicals for health, food, energy, materials and others. A systems approach to metabolic engineering has gained traction in recent years thanks to advances in strain engineering, leading to an accelerated scaling from rapid prototyping to industrial production. Metabolic engineering is nowadays on track towards a truly manufacturing technology, with reduced times from conception to production enabled by automated protocols for DNA assembly of metabolic pathways in engineered producer strains. In this review, we discuss how the success of the metabolic engineering pipeline often relies on retrobiosynthetic protocols able to identify promising production routes and dynamic regulation strategies through automated biodesign algorithms, which are subsequently assembled as embedded integrated genetic circuits in the host strain. Those approaches are orchestrated by an experimental design strategy that provides optimal scheduling planning of the DNA assembly, rapid prototyping and, ultimately, brings forward an accelerated Design-Build-Test-Learn cycle and the overall optimization of the biomanufacturing process. Achieving such a vision will address the increasingly compelling demand in our society for delivering valuable biomolecules in an affordable, inclusive and sustainable bioeconomy, IOM acknowledges funding from the Spanish Ministry of Science, Innovation and Universities and the European Union FEDER under grant SYNBIOCONTROL (DPI2017-82896-C2-2-R). PC acknowledges funding from Universitat Politècnica de València Talento Programme, the Spanish Ministry of Science, Innovation and Universities and the European Union FEDER under grant SYNBIOCONTROL (DPI2017-82896-C2-1-R) and European Union's Horizon 2020 research and innovation programme under grant agreement number 814408 (ShikiFactory100), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SelenzymeRF: updated enzyme suggestion software for unbalanced biochemical reactions

  • Stoney, Ruth A.
  • Hanko, Erik K.R.
  • Carbonell, Pablo
  • Breitling, Rainer
Selenzyme is a retrobiosynthesis tool that suggests candidate enzymes for user query reactions. Enzyme suggestions are based on identical reactions, as well as similar reactions, since enzymes are often capable of promiscuous substrate binding. Selenzyme is a user-friendly, widely used web-tool for ranking enzymes based on reaction similarity and additional features, including the phylogenetic distance between the source species of the enzyme and the intended host. While Selenzyme has proved invaluable in assisting with enzyme selection for known reactions, as well as many novel or orphan reactions, weaknesses have been exposed in its ability to rank functionally related enzymes. Within this update, we introduce a new reaction similarity scoring algorithm, which is used in conjunction with the previous similarity calculation, to improve the accuracy of enzyme suggestions based on non-identical similar reactions, across a range of EC reaction classes. This allows enzymes to be suggested for reactions not found within the database, even if the reaction is unbalanced. A database update was also carried out, to ensure that reaction and enzyme knowledge remains current. This update can be accessed at http://selenzymeRF.synbiochem.co.uk/., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 814408 SHIKIFACTORY100—Modular cell factories for the production of 100 compounds from the shikimate pathway. We acknowledge funding from the Biotechnology and Biological Sciences Research Council (BBSRC) under grant BB/M017702/1 “Centre for synthetic biology of fine and speciality chemicals (SYNBIOCHEM)”. Pablo Carbonell was supported by the Spanish Ministry of Universities (UNI/551/2021), grant number UP2021-036 funded by European Union-Next generation EU. Pablo Carbonell acknowledges funding from Generalitat Valenciana through grant CIAICO/2021/159 (SmartBioFab). Pablo Carbonell acknowledges MCIN/AEI/10.13039/501100011033 and NextGenerationEU/ PRTR funding through grant TED2021-131049B-I00 (BioEcoDBTL)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Computer-aided design and implementation of efficient biosynthetic pathways to produce high added-value products derived from tyrosine in Escherichia coli

  • Ferreira, Sofia
  • Balola, Alexandra
  • Sveshnikova, Anastasia
  • Hatzimanikatis, Vassily
  • Vilaça, Paulo
  • Maia, Paulo
  • Carreira, Rafael
  • Stoney, Ruth A.
  • Carbonell, Pablo
  • Silva Souza, Caio
  • Correia, João
  • Lousa, Diana
  • Soares, Cláudio M.
  • Rocha, Isabel
Developing efficient bioprocesses requires selecting the best biosynthetic pathways, which can be challenging and time-consuming due to the vast amount of data available in databases and literature. The extension of the shikimate pathway for the biosynthesis of commercially attractive molecules often involves promiscuous enzymes or lacks well-established routes. To address these challenges, we developed a computational workflow integrating enumeration/retrosynthesis algorithms, a toolbox for pathway analysis, enzyme selection tools, and a gene discovery pipeline, supported by manual curation and literature review. Our focus has been on implementing biosynthetic pathways for tyrosine-derived compounds, specifically L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine, with significant applications in health and nutrition. We selected one pathway to produce L-DOPA and two different pathways for dopamine-one already described in the literature and a novel pathway. Our goal was either to identify the most suitable gene candidates for expression in Escherichia coli for the known pathways or to discover innovative pathways. Although not all implemented pathways resulted in the accumulation of target compounds, in our shake-flask experiments we achieved a maximum L-DOPA titer of 0.71 g/L and dopamine titers of 0.29 and 0.21 g/L for known and novel pathways, respectively. In the case of L-DOPA, we utilized, for the first time, a mutant version of tyrosinase from Ralstonia solanacearum. Production of dopamine via the known biosynthesis route was accomplished by coupling the L-DOPA pathway with the expression of DOPA decarboxylase from Pseudomonas putida, resulting in a unique biosynthetic pathway never reported in literature before. In the context of the novel pathway, dopamine was produced using tyramine as the intermediate compound. To achieve this, tyrosine was initially converted into tyramine by expressing TDC from Levilactobacillus brevis, which, in turn, was converted into dopamine through the action of the enzyme encoded by ppoMP from Mucuna pruriens. This marks the first time that an alternative biosynthetic pathway for dopamine has been validated in microbes. These findings underscore the effectiveness of our computational workflow in facilitating pathway enumeration and selection, offering the potential to uncover novel biosynthetic routes, thus paving the way for other target compounds of biotechnological interest., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 814408 SHIKIFACTORY100–Modular cell factories for the production of 100 compounds from the Shikimate pathway. This work was supported by FCT–Fundação para a Ciência e a Tecnologia, I.P., through MOSTMICRO-ITQB R&D Unit (UIDB/04612/2020, UIDP/04612/2020) and LS4FUTURE Associated Laboratory (LA/P/0087/2020)., Peer reviewed